"We selected IMGM for our initial development of a blood-based test for the early detection of Alzheimer's disease. The high quality and control at all steps of the work at IMGM was essential for the development of our first CE-approved test, ADtect, and we would not hesitate to entrust them with further projects in the future."
Anders Lonneborg
Research Director, DiaGenic ASA